Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01518270|
Recruitment Status : Completed
First Posted : January 25, 2012
Results First Posted : December 5, 2012
Last Update Posted : December 5, 2012
|Condition or disease||Intervention/treatment|
|Health||Other: No treatment|
|Study Type :||Observational|
|Actual Enrollment :||179 participants|
|Observational Model:||Ecologic or Community|
|Study Start Date :||December 2011|
|Actual Primary Completion Date :||December 2011|
|Actual Study Completion Date :||December 2011|
Other: No treatment
No treatment will be provided
- Eyelash Length as Measured by Digital Image Analysis (DIA) [ Time Frame: Baseline ]Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis.
- Eyelash Thickness as Measured by Digital Image Analysis (DIA) [ Time Frame: Baseline ]Photographs were taken of the eyelashes. Eyelash thickness/fullness was assessed across both eyes as an average of the 3 preset areas measured in millimeters squared (mm^2).
- Eyelash Darkness as Measured by Digital Image Analysis (DIA) [ Time Frame: Baseline ]Photographs were taken of the Eyelashes. Eyelash darkness (intensity) was measured within the spline (a narrow area approximately 5 pixels wide that bisects the area of interest). Eyelash darkness was measured in both eyes and averaged for analysis using a scale where 0=black and 255=white.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01518270
|United States, California|
|Irvine, California, United States|
|Study Director:||Medical Director||Allergan|